10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0001628280-24-034114`
Period End Date	20240630
Filing Date	20240801
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	alhc-20240630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 160 Cash Flow Statement 158 Stockholders Equity 60

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$95.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$95.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $95 at June 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$183.21M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $95 at June 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$183.21M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $95 at June 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $95 at June 30, 2024 and $0 at December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$24.70M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$24.70M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$52.19M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$52.19M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$599.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$599.11M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.24M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.24M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$62.43M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$62.43M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.09M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.09M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.20M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.20M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.60M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.60M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Total assets	`Assets`	$716.26M	USD	Point-in-time
Total assets	`Assets`	$716.26M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$315.37M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$315.37M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.34M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.34M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$32.83M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$32.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$371.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$371.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$211.74M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$211.74M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.18M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.18M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$591.46M	USD	Point-in-time
Total liabilities	`Liabilities`	$591.46M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of June 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of June 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of June 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of June 30, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 191,236,747 and 188,951,643 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 191,236,747 and 188,951,643 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 191,236,747 and 188,951,643 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 191,236,747 and 188,951,643 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.07B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.07B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-950.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-950.79M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$123.70M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$123.70M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.09M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.09M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$716.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$716.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time

Income Statement 160 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$1.30B	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.30B	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$891.69M	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$891.69M	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$456.88M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$456.88M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$674.09M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$674.09M	USD	1 Quarter
Other Income	`OtherIncome`	$14.24M	USD	2 Qtrs
Other Income	`OtherIncome`	$14.24M	USD	2 Qtrs
Other Income	`OtherIncome`	$9.85M	USD	2 Qtrs
Other Income	`OtherIncome`	$9.85M	USD	2 Qtrs
Other Income	`OtherIncome`	$5.50M	USD	1 Quarter
Other Income	`OtherIncome`	$5.50M	USD	1 Quarter
Other Income	`OtherIncome`	$7.19M	USD	1 Quarter
Other Income	`OtherIncome`	$7.19M	USD	1 Quarter
Total revenues	`Revenues`	$462.38M	USD	1 Quarter
Total revenues	`Revenues`	$462.38M	USD	1 Quarter
Total revenues	`Revenues`	$901.53M	USD	2 Qtrs
Total revenues	`Revenues`	$901.53M	USD	2 Qtrs
Total revenues	`Revenues`	$1.31B	USD	2 Qtrs
Total revenues	`Revenues`	$1.31B	USD	2 Qtrs
Total revenues	`Revenues`	$681.29M	USD	1 Quarter
Total revenues	`Revenues`	$681.29M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$806.96M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$806.96M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$1.18B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$1.18B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$605.31M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$605.31M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$410.64M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$410.64M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$140.61M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$140.61M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$87.86M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$87.86M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$70.20M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$70.20M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$178.38M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$178.38M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.12M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.12M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.47M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.47M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.49M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.49M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.37B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$1.37B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$957.68M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$957.68M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$486.04M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$486.04M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$699.67M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$699.67M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.66M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.66M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-56.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-56.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-59.49M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-59.49M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$5.69M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.69M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$11.12M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$11.12M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$5.26M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.26M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$10.28M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$10.28M	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$428.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$428.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$92.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$92.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$50.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$50.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$566.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$566.00K	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-5.60M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-5.60M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-11.07M	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-11.07M	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-9.71M	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-9.71M	USD	2 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-4.83M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-4.83M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.98M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.98M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-70.56M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-70.56M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.49M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.49M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-65.86M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-65.86M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00K	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00K	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00K	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00K	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-104.00K	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-104.00K	USD	2 Qtrs
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-17.00K	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-17.00K	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-70.53M	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-70.53M	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-28.48M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-28.48M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-65.76M	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-65.76M	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-24.01M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-24.01M	USD	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.95M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.95M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	184.56M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	184.56M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.89M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.89M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	185.99M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	185.99M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.95M	shares	2 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.95M	shares	2 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	184.56M	shares	2 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	184.56M	shares	2 Qtrs
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	185.99M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	185.99M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.89M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.89M	shares	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.37	USD	2 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.37	USD	2 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.36	USD	2 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.36	USD	2 Qtrs
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.37	USD	2 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.37	USD	2 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.36	USD	2 Qtrs
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.36	USD	2 Qtrs

Cash Flow Statement 158 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$51.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$51.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$50.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$50.00K	USD	1 Quarter
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	2 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	2 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$289.00K	USD	2 Qtrs
Loss (gain) on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$289.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$10.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$10.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.57M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.57M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.76M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.76M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.72M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.72M	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$734.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$734.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$612.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$612.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.61M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.61M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$930.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$930.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.35M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$1.35M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$63.56M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$63.56M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.91M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.91M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$35.08M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$35.08M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.22M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.22M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-92.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-92.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$112.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$112.00K	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$109.97M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$109.97M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$37.06M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$37.06M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.37M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.37M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$147.17M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$147.17M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-310.00K	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-310.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.63M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.63M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.28M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.28M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.42M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.42M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.17M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.17M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$122.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$122.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.29M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$156.94M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$156.94M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$40.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$40.00M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$36.15M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$36.15M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$132.53M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$132.53M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.85M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.85M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.85M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.85M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-136.64M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-136.64M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$69.67M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$69.67M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$136.12M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$136.12M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-14.29M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-14.29M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$10.25M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$10.25M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.99M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.99M	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$42.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$42.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$122.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$122.00K	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.06M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.06M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	2 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.64M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.64M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.78M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.78M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.64M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.64M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.61M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.61M	USD	2 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	2 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	2 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$30.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$30.00K	USD	1 Quarter
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	2 Qtrs
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.24M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.